Dalla Lana School of Public Health, The University of Toronto, Toronto, Ontario, Canada (Ms Bhardwaj); Department of Cardiology, Women's College Hospital and Lawrence S. Bloomberg Faculty of Nursing, The University of Toronto, Toronto, Ontario, Canada (Dr Price); Department of Cardiology, Women's College Hospital, The University of Toronto, Toronto, Ontario, Canada (Ms Landry); and Cardiovascular Research Program (Dr Harvey) and Department of Psychiatry (Dr Hensel), Women's College Hospital, Women's College Research Institute, The University of Toronto, Toronto, Ontario, Canada.
J Cardiopulm Rehabil Prev. 2018 Sep;38(5):291-296. doi: 10.1097/HCR.0000000000000311.
Depression comorbid with cardiovascular disease is associated with higher rates of morbidity and mortality, with studies suggesting that this is especially true among women. This study examined depressive symptoms and their relationship to cardiac risk factors among women referred to a women's cardiac rehabilitation and primary prevention program.
A secondary analysis of data collected between 2004 and 2014 for 1075 women who completed a baseline assessment at the Women's Cardiovascular Health Initiative, a women-only cardiac rehabilitation and prevention program in Toronto, Canada. Descriptive statistics for sociodemographic variables, quality of life (SF-36), and cardiac risk factors were stratified by depression symptom severity using cutoff scores from the Beck Depression Inventory-2nd version (BDI-II) and compared with analysis of variance and χ statistics. Prevalence of antidepressant use among those with moderate to high depressive symptoms was assessed as an indicator of under- or untreated depression.
Overall, 38.6% of women scored above the BDI-II cutoff for depression; 23.6% in the moderate or severe range. Socioeconomic status and quality of life decreased with increasing depression severity. Body mass index increased with depressive severity (P < .001), as did the percentage of individuals with below target age predicted fitness (P < .001). Only 39.0% of women in the moderate and severe BDI-II groups were taking antidepressants.
In this sample, we found a significant prevalence of untreated and undertreated depressive symptoms among women with, or at high risk of developing, cardiovascular disease. Additional strategies are needed to identify these patients early and link them to appropriate treatment.
合并心血管疾病的抑郁症与更高的发病率和死亡率相关,有研究表明,这在女性中尤为明显。本研究检查了抑郁症状及其与女性心血管康复和初级预防计划中女性的心脏危险因素的关系。
对 2004 年至 2014 年间在加拿大多伦多的女性心血管健康倡议(仅限女性的心脏康复和预防计划)完成基线评估的 1075 名女性收集的数据进行二次分析。使用贝克抑郁量表第二版(BDI-II)的截断分数按抑郁症状严重程度对社会人口统计学变量、生活质量(SF-36)和心脏危险因素进行分层,并与方差分析和 χ 统计进行比较。评估中度至重度抑郁症状女性中使用抗抑郁药的比例,作为未治疗或治疗不足的抑郁的指标。
总体而言,38.6%的女性的贝克抑郁量表得分高于抑郁的截断值;23.6%处于中度或重度范围。社会经济地位和生活质量随着抑郁严重程度的增加而下降。体重指数随着抑郁严重程度的增加而增加(P<0.001),目标年龄以下预测健康的个体比例也增加(P<0.001)。仅 39.0%处于中重度贝克抑郁量表组的女性正在服用抗抑郁药。
在本研究中,我们发现患有或有发展为心血管疾病风险的女性中存在未治疗和治疗不足的抑郁症状的显著比例。需要采取额外的策略来早期识别这些患者,并将其与适当的治疗联系起来。